This announcement is a separate document:
诺诚健华医药有限公司关于2023年科创板限制性股票激励计划首次授予部分第一个归属期符合归属条件的公告
Innocare Pharmaceutical Co., Ltd.'s announcement on the first attribution period of the 2023 STAR market restricted stock incentive plan partially meeting the attribution conditions.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated